Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[Progress of demyelinating animal models in the central nervous system].
Multiple sclerosis: Phases of disease improvement unrelated to relapses.
Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis.
Recombinant Expression of Margatoxin and Agitoxin-2 in Pichia pastoris: An Efficient Method for Production of K(V)1.3 Channel Blockers.
Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis.
Chronic oligodendrogenesis and remyelination after spinal cord injury in mice and rats.
Myelination of rodent hippocampal neurons in culture.
[Current immunotherapy of multiple sclerosis].
P-glycoprotein regulates trafficking of CD8(+) T cells to the brain parenchyma.
[Quality of life of patients receiving long-term treatment with first-line disease-modifying drugs: results of a Russian multicenter study using MusiQoL.]
Detecting clinically-relevant changes in progressive multiple sclerosis.
Hierarchical conditional random fields for detection of gad-enhancing lesions in multiple sclerosis.
Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence.
Association of Neuromyelitis Optica With Severe and Intractable Pain.
B-cell-directed therapy: which B cells should be targeted and how?
Couples coping with multiple sclerosis: a dyadic perspective on the roles of mindfulness and acceptance.
Common and Low Frequency Variants in MERTK Are Independently Associated with Multiple Sclerosis Susceptibility with Discordant Association Dependent upon HLA-DRB1*15:01 Status.
The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells.
Obstetrical epidural and spinal anesthesia in multiple sclerosis.
Y-39983, a Selective Rho-Kinase Inhibitor, Attenuates Experimental Autoimmune Encephalomyelitis via Inhibition of Demyelination.
Melanoma complicating treatment with natalizumab for multiple sclerosis.
Biological and nonbiological complex drugs for multiple sclerosis in Latin America: regulations and risk management.
The therapeutic potential of cannabis and cannabinoids.
Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities.
Evaluation of Retinal Nerve Fiber Layer and Ganglion Cell Complex in Patients with Optic Neuritis or Neuromyelitis Optica Spectrum Disorders Using Optical Coherence Tomography in a Chinese Cohort.
Pages
« first
‹ previous
…
209
210
211
212
213
214
215
216
217
…
next ›
last »